Pub Date : 2026-01-01DOI: 10.30802/AALAS-JAALAS-25-171
Kevin M O'Brien, Layne E Freeman, Kristen D Esannason Munroe, Kristin L Gardiner
{"title":"Subcutaneous Cervical Mass in the Northern Tree Shrew (Tupaia belangeri).","authors":"Kevin M O'Brien, Layne E Freeman, Kristen D Esannason Munroe, Kristin L Gardiner","doi":"10.30802/AALAS-JAALAS-25-171","DOIUrl":"https://doi.org/10.30802/AALAS-JAALAS-25-171","url":null,"abstract":"","PeriodicalId":94111,"journal":{"name":"Journal of the American Association for Laboratory Animal Science : JAALAS","volume":" ","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146109357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.30802/AALAS-JAALAS-25-166
Michele A Basso, Kristin L Gardiner, Ginger Tansey, Sébastien Tremblay, Andrew Winterborn
The human-animal relationship is undergoing a profound cultural shift, reshaping how societies-and professionals-understand animal welfare. In biomedical research, these changing attitudes have begun to influence the role of laboratory animal veterinarians, whose work now sits at the intersection of care, ethics, and compliance. While compassion-driven caution is laudable, the growing tendency toward moral gatekeeping risks impeding ethically justified science. This piece argues for renewed partnership between veterinarians and scientists grounded in evidence, trust, and shared responsibility. Sustaining both animal welfare and scientific progress requires not greater division, but deliberate collaboration-anchored in the belief that ethical research involving animals is a moral good.
{"title":"The Shifting Role of the Laboratory Animal Veterinarian: An Emerging Concern.","authors":"Michele A Basso, Kristin L Gardiner, Ginger Tansey, Sébastien Tremblay, Andrew Winterborn","doi":"10.30802/AALAS-JAALAS-25-166","DOIUrl":"https://doi.org/10.30802/AALAS-JAALAS-25-166","url":null,"abstract":"<p><p>The human-animal relationship is undergoing a profound cultural shift, reshaping how societies-and professionals-understand animal welfare. In biomedical research, these changing attitudes have begun to influence the role of laboratory animal veterinarians, whose work now sits at the intersection of care, ethics, and compliance. While compassion-driven caution is laudable, the growing tendency toward moral gatekeeping risks impeding ethically justified science. This piece argues for renewed partnership between veterinarians and scientists grounded in evidence, trust, and shared responsibility. Sustaining both animal welfare and scientific progress requires not greater division, but deliberate collaboration-anchored in the belief that ethical research involving animals is a moral good.</p>","PeriodicalId":94111,"journal":{"name":"Journal of the American Association for Laboratory Animal Science : JAALAS","volume":" ","pages":"1-2"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146097772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.30802/AALAS-JAALAS-25-139
Catherine E Pope, Rheinallt M Jones, Ammar A Rashied, Tamas Nagy, Wai H Hanson
Upon importation, laboratory mice may undergo prophylactic antiparasitic treatment during quarantine to prevent the introduction of parasites into established colonies. While quarantine protocols vary across institutions, ivermectin is commonly used, administered either orally or topically. However, the impact of these practices on the fecal microbiome remains poorly understood, raising concerns about unintended consequences for experimental outcomes. This study investigated the effects of ivermectin on fecal microbiome composition in naïve, healthy male and female C57BL/6J mice. Animals received either ivermectin-impregnated feed (12 ppm, ad libitum for 4 weeks), weekly topical ivermectin solution (2.0 mg/kg for 4 weeks), or no treatment (controls). Fecal samples were collected for 16S rRNA-based microbiome analysis before ivermectin treatment, immediately posttreatment, and 4 weeks after treatment cessation. Weekly body weights were recorded, and histopathologic evaluation of the small intestine and colon was performed at study completion. Both oral and topical ivermectin treatments resulted in significant alterations in microbiome α and β diversity at the end of treatment, with more pronounced effects observed in female mice. Some of these changes persisted for up to 4 weeks after treatment cessation. Furthermore, the findings indicate a sex-specific effect of ivermectin on specific bacterial orders, with Bacillales predominantly affected in male mice, whereas Coriobacteriales and Bacteriodales were primarily impacted in female mice. During treatment, males receiving topical ivermectin weighed significantly less than controls, while females receiving dietary ivermectin weighed significantly more. Histopathological analysis revealed no abnormalities in intestinal tissues across all groups at 4 weeks posttreatment. These findings demonstrate that ivermectin administration induces measurable and persistent changes in the fecal microbiome of healthy mice. Researchers should consider these effects when designing experiments, and institutions must weigh the benefits of colony protection against potential microbiome-related confounding variables.
{"title":"Evaluating the Impact of Prophylactic Administration of Ivermectin on the Fecal Microbiome of Healthy C57BL/6J Mice (Mus musculus).","authors":"Catherine E Pope, Rheinallt M Jones, Ammar A Rashied, Tamas Nagy, Wai H Hanson","doi":"10.30802/AALAS-JAALAS-25-139","DOIUrl":"10.30802/AALAS-JAALAS-25-139","url":null,"abstract":"<p><p>Upon importation, laboratory mice may undergo prophylactic antiparasitic treatment during quarantine to prevent the introduction of parasites into established colonies. While quarantine protocols vary across institutions, ivermectin is commonly used, administered either orally or topically. However, the impact of these practices on the fecal microbiome remains poorly understood, raising concerns about unintended consequences for experimental outcomes. This study investigated the effects of ivermectin on fecal microbiome composition in naïve, healthy male and female C57BL/6J mice. Animals received either ivermectin-impregnated feed (12 ppm, ad libitum for 4 weeks), weekly topical ivermectin solution (2.0 mg/kg for 4 weeks), or no treatment (controls). Fecal samples were collected for 16S rRNA-based microbiome analysis before ivermectin treatment, immediately posttreatment, and 4 weeks after treatment cessation. Weekly body weights were recorded, and histopathologic evaluation of the small intestine and colon was performed at study completion. Both oral and topical ivermectin treatments resulted in significant alterations in microbiome α and β diversity at the end of treatment, with more pronounced effects observed in female mice. Some of these changes persisted for up to 4 weeks after treatment cessation. Furthermore, the findings indicate a sex-specific effect of ivermectin on specific bacterial orders, with Bacillales predominantly affected in male mice, whereas Coriobacteriales and Bacteriodales were primarily impacted in female mice. During treatment, males receiving topical ivermectin weighed significantly less than controls, while females receiving dietary ivermectin weighed significantly more. Histopathological analysis revealed no abnormalities in intestinal tissues across all groups at 4 weeks posttreatment. These findings demonstrate that ivermectin administration induces measurable and persistent changes in the fecal microbiome of healthy mice. Researchers should consider these effects when designing experiments, and institutions must weigh the benefits of colony protection against potential microbiome-related confounding variables.</p>","PeriodicalId":94111,"journal":{"name":"Journal of the American Association for Laboratory Animal Science : JAALAS","volume":" ","pages":"1-8"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146097774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.30802/AALAS-JAALAS-25-143
Laurentiu Benga, W Peter M Benten, Sabine J Bischoff, Henrik Christensen
The former [Pasteurella] pneumotropica complex has rendered until now 12 Rodentibacter species, which has implications in the monitoring of these highly prevalent laboratory rodent microorganisms. Rodentibacter spp. are known as classic opportunistic pathogens of laboratory rodents and represent noteworthy members of the oral and genital microbiome, with potential pathophysiological interferences in colonized animals. Laboratory mice and rats are predominantly colonized by host-specific Rodentibacter spp., with R. pneumotropicus and R. heylii as mouse-specific species and R. ratti, R. heidelbergensis, R. rarus, and R. trehalosifermentans as rat-specific species; however, host specificity of R. haemolyticus, currently prevalent in both species, remains to be elucidated. Nevertheless, cross contaminations with the taxa from the opposite host occurs between mice and rats. The monitoring occurs by classic culture and/or by molecular techniques, although the latter are currently available only for a few Rodentibacter taxa. Unfortunately, many current health monitoring strategies do not take into consideration the host specificities of these taxa and are often focused nearly exclusively on the molecular diagnostics of R. pneumotropicus and R. heylii, thus neglecting the remaining taxa. Until future research addresses the lack of molecular tests available for all relevant Rodentibacter spp. and a host-specific monitoring is implemented, we consider that monitoring exclusively by current molecular methods risks missing opportunistic members of this genus. Importing laboratory rodents based on health reports relying solely on molecular assays is currently associated with an increased risk of accepting Rodentibacter-positive animals.
{"title":"Why Is the Current Monitoring of Rodentibacter spp. Exclusively by Molecular Methods Insufficient?","authors":"Laurentiu Benga, W Peter M Benten, Sabine J Bischoff, Henrik Christensen","doi":"10.30802/AALAS-JAALAS-25-143","DOIUrl":"10.30802/AALAS-JAALAS-25-143","url":null,"abstract":"<p><p>The former [Pasteurella] pneumotropica complex has rendered until now 12 Rodentibacter species, which has implications in the monitoring of these highly prevalent laboratory rodent microorganisms. Rodentibacter spp. are known as classic opportunistic pathogens of laboratory rodents and represent noteworthy members of the oral and genital microbiome, with potential pathophysiological interferences in colonized animals. Laboratory mice and rats are predominantly colonized by host-specific Rodentibacter spp., with R. pneumotropicus and R. heylii as mouse-specific species and R. ratti, R. heidelbergensis, R. rarus, and R. trehalosifermentans as rat-specific species; however, host specificity of R. haemolyticus, currently prevalent in both species, remains to be elucidated. Nevertheless, cross contaminations with the taxa from the opposite host occurs between mice and rats. The monitoring occurs by classic culture and/or by molecular techniques, although the latter are currently available only for a few Rodentibacter taxa. Unfortunately, many current health monitoring strategies do not take into consideration the host specificities of these taxa and are often focused nearly exclusively on the molecular diagnostics of R. pneumotropicus and R. heylii, thus neglecting the remaining taxa. Until future research addresses the lack of molecular tests available for all relevant Rodentibacter spp. and a host-specific monitoring is implemented, we consider that monitoring exclusively by current molecular methods risks missing opportunistic members of this genus. Importing laboratory rodents based on health reports relying solely on molecular assays is currently associated with an increased risk of accepting Rodentibacter-positive animals.</p>","PeriodicalId":94111,"journal":{"name":"Journal of the American Association for Laboratory Animal Science : JAALAS","volume":" ","pages":"1-4"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12878841/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145746315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.30802/AALAS-JAALAS-25-117
Emma L Santoro, Jeffrey D Fortman, Kristen M Messenger, Hiroko Enomoto, Lisa C Halliday
Pain management is an expansive and ever-evolving component of managing nonhuman primates in the research setting. Opioids are a commonly used analgesic medication and are available in a variety of formulations. A novel, long-acting transdermal buprenorphine topical solution was recently approved for use in cats to provide up to 4 days of postoperative analgesia. The purpose of this study was to evaluate the pharmacokinetic profile of this transdermal formulation in cynomolgus macaques. Five male cynomolgus macaques were used in a 2-formulation crossover study to compare the pharmacokinetics of a single transdermal dose (20 mg) to a single intravenous dose of buprenorphine HCl (0.01 mg/kg). Plasma buprenorphine levels were measured for animals receiving transdermal buprenorphine topical solution at time points 0 (baseline), 1, 3, 6, 12, 24, 36, 48, 72, 96, and 120 hours postdosing. Plasma buprenorphine levels were measured for animals receiving intravenous buprenorphine at time points 0 (baseline), 2, 5, 10, 25, 45, and 60 minutes and at 3, 6, 12, and 24 hours postdosing. Animals weighing 3.55-6.2 kg reached therapeutic plasma levels, as hypothesized in the literature (0.1 ng/mL), within 1 hour of administration and maintained therapeutic levels for at least 72 hours. This study demonstrates that this novel transdermal buprenorphine topical solution can offer a refinement in pain management of nonhuman primates through a less invasive route of administration with an extended duration of action.
{"title":"Pharmacokinetics of a Transdermal Buprenorphine Topical Solution in the Cynomolgus Macaque (Macaca fascicularis).","authors":"Emma L Santoro, Jeffrey D Fortman, Kristen M Messenger, Hiroko Enomoto, Lisa C Halliday","doi":"10.30802/AALAS-JAALAS-25-117","DOIUrl":"10.30802/AALAS-JAALAS-25-117","url":null,"abstract":"<p><p>Pain management is an expansive and ever-evolving component of managing nonhuman primates in the research setting. Opioids are a commonly used analgesic medication and are available in a variety of formulations. A novel, long-acting transdermal buprenorphine topical solution was recently approved for use in cats to provide up to 4 days of postoperative analgesia. The purpose of this study was to evaluate the pharmacokinetic profile of this transdermal formulation in cynomolgus macaques. Five male cynomolgus macaques were used in a 2-formulation crossover study to compare the pharmacokinetics of a single transdermal dose (20 mg) to a single intravenous dose of buprenorphine HCl (0.01 mg/kg). Plasma buprenorphine levels were measured for animals receiving transdermal buprenorphine topical solution at time points 0 (baseline), 1, 3, 6, 12, 24, 36, 48, 72, 96, and 120 hours postdosing. Plasma buprenorphine levels were measured for animals receiving intravenous buprenorphine at time points 0 (baseline), 2, 5, 10, 25, 45, and 60 minutes and at 3, 6, 12, and 24 hours postdosing. Animals weighing 3.55-6.2 kg reached therapeutic plasma levels, as hypothesized in the literature (0.1 ng/mL), within 1 hour of administration and maintained therapeutic levels for at least 72 hours. This study demonstrates that this novel transdermal buprenorphine topical solution can offer a refinement in pain management of nonhuman primates through a less invasive route of administration with an extended duration of action.</p>","PeriodicalId":94111,"journal":{"name":"Journal of the American Association for Laboratory Animal Science : JAALAS","volume":" ","pages":"1-7"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12878920/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145784230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.30802/AALAS-JAALAS-25-142
Amanda N Reis, Mariana C Sanches, Mariana Aad Henriques, Jaqueline N Pizzaia, Elidiane Rusch, Bruno B D Muro, Cesar A P Garbossa, Adriano B Carregaro
The study described here evaluated the efficacy of supplemental oxygen in preventing hypoxemia (pO2 < 80 mm Hg) in pigs chemically restrained with ketamine, dexmedetomidine, and diazepam. Twenty gilts (154.5 ± 4.8 kg, 250 ± 2 days old) received a combination of ketamine (2 mg/kg), dexmedetomidine (10 µg/kg), and diazepam (0.1 mg/kg) via the auricular vein. Following induction, animals were positioned in right lateral recumbency and assigned to receive either ambient air (ambient air group, n = 10) or 100% oxygen at 5 L/min via a nasal cannula inserted 16 cm into one nostril (oxygen group, n = 10). Heart rate, peripheral oxygen saturation, and rectal temperature were monitored every 5 minutes. Arterial blood samples were collected at 5, 15, and 30 minutes to assess blood gas and electrolyte parameters. Induction time, time to sternal recumbency, time to standing, and recovery quality were also recorded. All gilts in the ambient air group developed hypoxemia, whereas those in the oxygen group maintained pO2 > 80 mm Hg. Peripheral oxygen saturation values were consistently higher in the oxygen group, whereas HR, respiratory rate, and temperature did not differ significantly between groups. Induction and recovery times, as well as recovery quality scores, were also similar between groups. Intranasal oxygen supplementation at 5 L/min effectively maintained arterial oxygenation and prevented hypoxemia in gilts anesthetized with the ketamine-dexmedetomidine-diazepam combination.
本研究评估了补充氧对氯胺酮、右美托咪定和地西泮化学抑制猪低氧血症(pO2 < 80 mm Hg)的预防效果。20头(154.5±4.8 kg, 250±2日龄)的后备母猪通过耳静脉给予氯胺酮(2mg /kg)、右美托咪定(10µg/kg)和地西泮(0.1 mg/kg)。诱导后,将动物置于右侧侧卧位,分别接受环境空气(环境空气组,n = 10)或5l /min的100%氧气,通过插入鼻孔16 cm的鼻插管(氧气组,n = 10)。心率、外周血氧饱和度、直肠温度每5分钟监测一次。分别于5、15和30分钟采集动脉血样本,评估血气和电解质参数。同时记录诱导时间、至胸骨平卧时间、站立时间和恢复质量。环境空气组的所有后备母猪都出现了低氧血症,而氧气组的后备母猪维持了pO2 bb0 80 mm Hg。氧气组的外周氧饱和度值一直较高,而HR、呼吸速率和温度在两组之间没有显著差异。诱导和恢复时间以及恢复质量得分在两组之间也相似。用氯胺酮-右美托咪定-地西泮联合麻醉的后备母猪,以5 L/min的速度鼻内补氧可有效维持动脉氧合,防止低氧血症。
{"title":"Supplemental Oxygen Prevents Hypoxemia in Pigs (Sus domesticus) Chemically Restrained with Ketamine, Dexmedetomidine, and Diazepam.","authors":"Amanda N Reis, Mariana C Sanches, Mariana Aad Henriques, Jaqueline N Pizzaia, Elidiane Rusch, Bruno B D Muro, Cesar A P Garbossa, Adriano B Carregaro","doi":"10.30802/AALAS-JAALAS-25-142","DOIUrl":"10.30802/AALAS-JAALAS-25-142","url":null,"abstract":"<p><p>The study described here evaluated the efficacy of supplemental oxygen in preventing hypoxemia (pO2 < 80 mm Hg) in pigs chemically restrained with ketamine, dexmedetomidine, and diazepam. Twenty gilts (154.5 ± 4.8 kg, 250 ± 2 days old) received a combination of ketamine (2 mg/kg), dexmedetomidine (10 µg/kg), and diazepam (0.1 mg/kg) via the auricular vein. Following induction, animals were positioned in right lateral recumbency and assigned to receive either ambient air (ambient air group, n = 10) or 100% oxygen at 5 L/min via a nasal cannula inserted 16 cm into one nostril (oxygen group, n = 10). Heart rate, peripheral oxygen saturation, and rectal temperature were monitored every 5 minutes. Arterial blood samples were collected at 5, 15, and 30 minutes to assess blood gas and electrolyte parameters. Induction time, time to sternal recumbency, time to standing, and recovery quality were also recorded. All gilts in the ambient air group developed hypoxemia, whereas those in the oxygen group maintained pO2 > 80 mm Hg. Peripheral oxygen saturation values were consistently higher in the oxygen group, whereas HR, respiratory rate, and temperature did not differ significantly between groups. Induction and recovery times, as well as recovery quality scores, were also similar between groups. Intranasal oxygen supplementation at 5 L/min effectively maintained arterial oxygenation and prevented hypoxemia in gilts anesthetized with the ketamine-dexmedetomidine-diazepam combination.</p>","PeriodicalId":94111,"journal":{"name":"Journal of the American Association for Laboratory Animal Science : JAALAS","volume":" ","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12878886/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145784199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mice are a valuable tool for preclinical research, enabling the investigation of fundamental questions about disease mechanisms, drug delivery, and pharmacokinetics. Intestinal pH influences drug delivery and pharmacokinetics of orally administered compounds. However, little is known about variations in pH along different sections of the mouse gastrointestinal tract. We therefore compared pH in 7 gastrointestinal tract sections of 48 male and female BALB/c, C57BL/6, and NMRI mice from 2 different vendors, as well as 8 streptomycin-treated and 8 germ-free BALB/c male and female mice from one vendor. The pH in the duodenum and cecum varied between strains and vendors. Relative to untreated barrier-bred mice, streptomycin-treated mice had significantly higher pH in the jejunum, and germ-free mice had significantly higher pH in the jejunum, cecum, and proximal colon, underlining the role of gut microbes in regulating pH levels throughout the gastrointestinal tract. In conclusion, we show that mouse strain, vendor, and microbial presence, but not sex, influence gastrointestinal pH in mice. Given the importance of gastrointestinal pH for pharmacokinetics, drug delivery systems, and gastrointestinal microbial behavior, these data will provide an important foundation for the choice of mouse models for research involving the gastrointestinal tract.
{"title":"Gastrointestinal Intraluminal pH of Non-Fasted Mice (Mus musculus) of Various Strains and Vendors Including Germ-Free and Streptomycin-Treated Mice.","authors":"Frida Cecilie Abalos Jensen, Jesper Samsø Birch, Aurelie Gram, Camilla Hartmann Friis Hansen, Dennis Sandris Nielsen","doi":"10.30802/AALAS-JAALAS-25-093","DOIUrl":"10.30802/AALAS-JAALAS-25-093","url":null,"abstract":"<p><p>Mice are a valuable tool for preclinical research, enabling the investigation of fundamental questions about disease mechanisms, drug delivery, and pharmacokinetics. Intestinal pH influences drug delivery and pharmacokinetics of orally administered compounds. However, little is known about variations in pH along different sections of the mouse gastrointestinal tract. We therefore compared pH in 7 gastrointestinal tract sections of 48 male and female BALB/c, C57BL/6, and NMRI mice from 2 different vendors, as well as 8 streptomycin-treated and 8 germ-free BALB/c male and female mice from one vendor. The pH in the duodenum and cecum varied between strains and vendors. Relative to untreated barrier-bred mice, streptomycin-treated mice had significantly higher pH in the jejunum, and germ-free mice had significantly higher pH in the jejunum, cecum, and proximal colon, underlining the role of gut microbes in regulating pH levels throughout the gastrointestinal tract. In conclusion, we show that mouse strain, vendor, and microbial presence, but not sex, influence gastrointestinal pH in mice. Given the importance of gastrointestinal pH for pharmacokinetics, drug delivery systems, and gastrointestinal microbial behavior, these data will provide an important foundation for the choice of mouse models for research involving the gastrointestinal tract.</p>","PeriodicalId":94111,"journal":{"name":"Journal of the American Association for Laboratory Animal Science : JAALAS","volume":" ","pages":"1-7"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12878846/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145835594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.30802/AALAS-JAALAS-25-073
Emory Lewis, Mia I Rough, Brianna F Roberts, Marissa B Costa, Paul W Czoty, Michael A Nader
In preclinical models, indwelling intravenous catheters and vascular access ports are often essential components of biomedical research aimed at modeling human disease. For instance, animal models of drug self-administration are used for many reasons, including to assess abuse liability, to study physiologic and neurologic consequences of drug exposure, and to examine the efficacy of behavioral and/or pharmacological interventions. The most frequent route of drug self-administration in preclinical animal models is the intravenous route via indwelling intravenous catheters. The present study examined 23 years of drug self-administration studies in Old World macaques used in drug self-administration studies at Wake Forest University School of Medicine. The medical records for individually or pair-housed adult rhesus monkeys (n = 10 females and 172 males) and socially housed cynomolgus monkeys (n = 64 females and 92 males), all implanted with indwelling intravenous catheters and associated vascular access ports, were examined. The most frequent vein catheterized was the femoral vein, followed by the internal and external jugular vein; the least frequent was the brachial vein. The infection rates over 23 years and >500 catheters in cynomolgus and rhesus monkeys were 13.7% and 10.3%, respectively. The average catheter remained patent and implanted in the vein for 22.5 months in cynomolgus monkeys and 15.5 months in rhesus monkeys. These findings highlight significant strengths in using Old World macaques, both rhesus and cynomolgus, in long-term, longitudinal studies involving indwelling intravenous catheters.
{"title":"Longevity and Catheter-Related Infection Rates in Nonhuman Primates with Chronic Indwelling Intravenous Catheters.","authors":"Emory Lewis, Mia I Rough, Brianna F Roberts, Marissa B Costa, Paul W Czoty, Michael A Nader","doi":"10.30802/AALAS-JAALAS-25-073","DOIUrl":"10.30802/AALAS-JAALAS-25-073","url":null,"abstract":"<p><p>In preclinical models, indwelling intravenous catheters and vascular access ports are often essential components of biomedical research aimed at modeling human disease. For instance, animal models of drug self-administration are used for many reasons, including to assess abuse liability, to study physiologic and neurologic consequences of drug exposure, and to examine the efficacy of behavioral and/or pharmacological interventions. The most frequent route of drug self-administration in preclinical animal models is the intravenous route via indwelling intravenous catheters. The present study examined 23 years of drug self-administration studies in Old World macaques used in drug self-administration studies at Wake Forest University School of Medicine. The medical records for individually or pair-housed adult rhesus monkeys (n = 10 females and 172 males) and socially housed cynomolgus monkeys (n = 64 females and 92 males), all implanted with indwelling intravenous catheters and associated vascular access ports, were examined. The most frequent vein catheterized was the femoral vein, followed by the internal and external jugular vein; the least frequent was the brachial vein. The infection rates over 23 years and >500 catheters in cynomolgus and rhesus monkeys were 13.7% and 10.3%, respectively. The average catheter remained patent and implanted in the vein for 22.5 months in cynomolgus monkeys and 15.5 months in rhesus monkeys. These findings highlight significant strengths in using Old World macaques, both rhesus and cynomolgus, in long-term, longitudinal studies involving indwelling intravenous catheters.</p>","PeriodicalId":94111,"journal":{"name":"Journal of the American Association for Laboratory Animal Science : JAALAS","volume":" ","pages":"1-7"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12878834/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145688804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.30802/AALAS-JAALAS-25-111
Jenna Schoenberger, Chago J Bowers, George P Langan, Kerith R Luchins
Segmented filamentous bacteria (SFB), or Candidatus savagella, are gram-positive, spore-forming, filamentous commensal bacteria that colonize the ilea of mice and rats. SFB can impact certain research studies due to their effect on the innate and adaptive immune system. Therefore, there is a need to eliminate SFB from some rodent colonies. Antibiotics are an effective treatment method that have been shown to be successful at eradicating this bacterium. Commonly, antibiotics are supplied to rodents via water. However, antibiotics in water have several limitations, depending on the type of water and the length of time in water, and administration is labor intensive. Therefore, this study sought to create a rodent diet containing the antibiotic ampicillin. The feed was constructed to counter an expected ampicillin concentration decrease from the pelleting process and irradiation. Mice were placed on the ampicillin feed for 4 weeks, and SFB was measured via PCR fecal analysis. After one week of feeding the ampicillin diet, all mice in the treatment group were negative for SFB. These mice remained negative for 2 additional weeks after treatment cessation. This study shows ampicillin diet is an effective method to eliminate SFB from mouse colonies.
{"title":"The Use of Ampicillin-Medicated Diet to Treat Segmented Filamentous Bacteria in a Mouse (Mus musculus) Colony.","authors":"Jenna Schoenberger, Chago J Bowers, George P Langan, Kerith R Luchins","doi":"10.30802/AALAS-JAALAS-25-111","DOIUrl":"10.30802/AALAS-JAALAS-25-111","url":null,"abstract":"<p><p>Segmented filamentous bacteria (SFB), or Candidatus savagella, are gram-positive, spore-forming, filamentous commensal bacteria that colonize the ilea of mice and rats. SFB can impact certain research studies due to their effect on the innate and adaptive immune system. Therefore, there is a need to eliminate SFB from some rodent colonies. Antibiotics are an effective treatment method that have been shown to be successful at eradicating this bacterium. Commonly, antibiotics are supplied to rodents via water. However, antibiotics in water have several limitations, depending on the type of water and the length of time in water, and administration is labor intensive. Therefore, this study sought to create a rodent diet containing the antibiotic ampicillin. The feed was constructed to counter an expected ampicillin concentration decrease from the pelleting process and irradiation. Mice were placed on the ampicillin feed for 4 weeks, and SFB was measured via PCR fecal analysis. After one week of feeding the ampicillin diet, all mice in the treatment group were negative for SFB. These mice remained negative for 2 additional weeks after treatment cessation. This study shows ampicillin diet is an effective method to eliminate SFB from mouse colonies.</p>","PeriodicalId":94111,"journal":{"name":"Journal of the American Association for Laboratory Animal Science : JAALAS","volume":" ","pages":"1-6"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12878840/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145717115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.30802/AALAS-JAALAS-25-165
Alfonso S Gozalo, Marisa C St Claire, William R Elkins
A female, research-naive, strain 13 guinea pig with no previous significant health history was noted to have a persistent vaginal discharge. On physical examination a soft mass was noted in the lower abdomen accompanied by a serosanguineous vaginal discharge. Due to a poor prognosis, the animal was euthanized. At necropsy, the left uterine horn was markedly enlarged and contained a large amorphous mass. Light microscopy examination showed that the mass had dense areas containing stromal cells surrounded by connective tissue, congested blood vessels, areas of necrosis, hemorrhage, and occasional cyst formation. In some areas numerous bacteria, both rods and cocci, were noted and the uterine wall showed increased thickness caused by a polymorphonuclear cell inflammatory infiltrate. Bacteriological culture and isolation from the vaginal discharge revealed a mixed infection with Escherichia coli, Bacteroides fragilis, Proteus mirabilis, Enterococcus spp., and α-hemolytic Streptococcus spp. while culture and isolation from the uterus revealed a mixed infection with E. coli, Pseudomonas aeruginosa, B. fragilis, and Globicatella sanguinis. The pathology findings were consistent with decidual cell reaction and endometritis. Vaginal bleeding is not a common clinical sign in decidual cell reaction and usually does not require treatment since the lesion in many cases resolves on its own by apoptosis and resorption. However, in this case, systemic antibiotics may have been beneficial to treat the endometrial infection. These findings suggest that decidual cell reactions may occur accompanied by, or as a result of, intrauterine infections in guinea pigs. The potential role of bacteria in decidual cell reaction should be further explored in guinea pigs.
{"title":"Decidual Cell Reaction and Endometritis in a Guinea Pig.","authors":"Alfonso S Gozalo, Marisa C St Claire, William R Elkins","doi":"10.30802/AALAS-JAALAS-25-165","DOIUrl":"https://doi.org/10.30802/AALAS-JAALAS-25-165","url":null,"abstract":"<p><p>A female, research-naive, strain 13 guinea pig with no previous significant health history was noted to have a persistent vaginal discharge. On physical examination a soft mass was noted in the lower abdomen accompanied by a serosanguineous vaginal discharge. Due to a poor prognosis, the animal was euthanized. At necropsy, the left uterine horn was markedly enlarged and contained a large amorphous mass. Light microscopy examination showed that the mass had dense areas containing stromal cells surrounded by connective tissue, congested blood vessels, areas of necrosis, hemorrhage, and occasional cyst formation. In some areas numerous bacteria, both rods and cocci, were noted and the uterine wall showed increased thickness caused by a polymorphonuclear cell inflammatory infiltrate. Bacteriological culture and isolation from the vaginal discharge revealed a mixed infection with Escherichia coli, Bacteroides fragilis, Proteus mirabilis, Enterococcus spp., and α-hemolytic Streptococcus spp. while culture and isolation from the uterus revealed a mixed infection with E. coli, Pseudomonas aeruginosa, B. fragilis, and Globicatella sanguinis. The pathology findings were consistent with decidual cell reaction and endometritis. Vaginal bleeding is not a common clinical sign in decidual cell reaction and usually does not require treatment since the lesion in many cases resolves on its own by apoptosis and resorption. However, in this case, systemic antibiotics may have been beneficial to treat the endometrial infection. These findings suggest that decidual cell reactions may occur accompanied by, or as a result of, intrauterine infections in guinea pigs. The potential role of bacteria in decidual cell reaction should be further explored in guinea pigs.</p>","PeriodicalId":94111,"journal":{"name":"Journal of the American Association for Laboratory Animal Science : JAALAS","volume":" ","pages":"1-4"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145867129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}